User contributions for JDoerfler
15 July 2024
- 12:3412:34, 15 July 2024 diff hist +2,792 Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study No edit summary
- 12:3312:33, 15 July 2024 diff hist +28 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 12:3212:32, 15 July 2024 diff hist −29 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 12:3012:30, 15 July 2024 diff hist +4,383 N Hejazi et al. (2016): Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study Created page with "{{Reference |Reference=Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo cap..."
- 12:2912:29, 15 July 2024 diff hist +1,726 N Publication: Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study Created page with "{{Publication |Title=Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Hejazi, E; Ehtejab, G; Hara, N |Year=2016 |Journal=Nutrition and Cancer |DOI=https://doi.org/10.1080/01635581.2016.1115527 |Authors Abstract=Curcumin is an antioxidant agent with both radiosensitizing and radioprot..." current
- 12:2312:23, 15 July 2024 diff hist 0 Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer No edit summary
- 12:2312:23, 15 July 2024 diff hist +8,164 N Hejazi et al. (2013): A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer Created page with "{{Reference |Reference=Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer }} {{Study Note |Study Note=One study in two publications. Further endpoints are reported in XX. }} =Brief summary= Prostate cancer patients were examined in this study. One half took curcumin capsules three times a day during radiotherapy and the other half took placebo capsules instead. In the first study of XX, the quality..."
- 11:5611:56, 15 July 2024 diff hist +2,133 N Publication: A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer Created page with "{{Publication |Title=A pilot clinical trial of radioprotective effects of curcumin supplementation in patients with prostate cancer |Topic=Curcumin |Author=Hejazi, J; Rastmanesh, R; Taleban, F-A; Molana, SH; Ehtejab, G |Year=2013 |Journal=Journal of Cancer Science and Therapy |DOI=http://dx.doi.org/10.4172/1948-5956.1000223 |Authors Abstract=Background: Patients with prostate cancer who accede to radiation therapy usually experience several side effects and these toxicit..." current
- 11:2911:29, 15 July 2024 diff hist +77 Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study No edit summary
- 11:2511:25, 15 July 2024 diff hist +986 Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study No edit summary
- 10:0010:00, 15 July 2024 diff hist +1,475 Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study No edit summary
- 09:4109:41, 15 July 2024 diff hist +3,294 N Dias et al. (2015): The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study Created page with "{{Reference |Reference=Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study }} {{Study Note}} =Brief summary= Cisplatin is an effective chemotherapeutic agent. However, cisplatin is toxic to the outer hair cells of the ears and can cause hearing loss in patients receiving this therapy. In this study, the researchers tested the effect of Ginkgo biloba extract at a dose of 120 mg twice daily to prevent damage to..."
- 09:4009:40, 15 July 2024 diff hist +2,061 N Publication: The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study Created page with "{{Publication |Title=The chemopreventive effect of Ginkgo biloba extract 761 against cisplatin ototoxicity: a pilot study |Topic=Ginkgo |Author=Dias, MA; Sampaio, ALL; Venosa, AR; Meneses, EA; Oliveira, CACP |Year=2015 |Journal=International Tinnitus Journal |DOI=https://doi.org/10.5935/0946-5448.20150003 |Authors Abstract=Objective: The purpose of this study was to evaluate, by using distortion product otoacoustic emission test, the action of Ginkgo biloba extract 761,..." current
- 09:3309:33, 15 July 2024 diff hist +25 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 09:3109:31, 15 July 2024 diff hist +867 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 09:2609:26, 15 July 2024 diff hist +755 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 09:1609:16, 15 July 2024 diff hist +1,097 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 09:0809:08, 15 July 2024 diff hist +354 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 09:0109:01, 15 July 2024 diff hist +340 Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 08:5308:53, 15 July 2024 diff hist +3,626 N Dardano et al. (2012): The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 Created page with "{{Reference |Reference=Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 }} {{Study Note}} =Brief summary= Differentiated thyroid cancer (DTC) is a type of thyroid cancer that has developed in the cells of the thyroid gland that are responsible for the production of thyroid hormones. DTC is usually treated by removing the thyroid gland followed by radio..."
- 08:5108:51, 15 July 2024 diff hist +22 Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary current
- 08:5108:51, 15 July 2024 diff hist +99 Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 08:4908:49, 15 July 2024 diff hist 0 Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 No edit summary
- 08:4908:49, 15 July 2024 diff hist +2,734 N Publication: The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 Created page with "{{Publication |Title=The effect of Ginkgo biloba extract on genotoxic damage in patients with differentiated thyroid carcinoma receiving thyroid remnant ablation with Iodine-131 |Topic=Ginkgo |Author=Dardano, A; Ballardin, M; Caraccio, N; Boni, G; Traino, C; Mariani, G; Ferdeghini, M; Barale, R; Monzani, F |Year=2012 |Journal=Thyroid |DOI=https://doi.org/10.1089/thy.2010.0398 |Authors Abstract=Background: Radioiodine (131I) therapy is usually performed in patients with d..."
- 07:5607:56, 15 July 2024 diff hist +2 Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy No edit summary
- 07:5407:54, 15 July 2024 diff hist −8 Vitale et al. (2020): ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy No edit summary
12 July 2024
- 12:4812:48, 12 July 2024 diff hist +1,294 Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer No edit summary
- 12:4612:46, 12 July 2024 diff hist −19 Laali et al. (2020): Effect of Selenium on Incidence and Severity of Mucositis during Radiotherapy in Patients with Head and Neck Cancer No edit summary
- 12:4512:45, 12 July 2024 diff hist −19 Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients No edit summary
- 12:4512:45, 12 July 2024 diff hist −19 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
- 12:4412:44, 12 July 2024 diff hist −19 Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization No edit summary
- 12:4412:44, 12 July 2024 diff hist +546 Muecke et al. (2014): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology: follow-up analysis of the survival data 6 years after cessation of randomization No edit summary
- 12:4412:44, 12 July 2024 diff hist +546 Muecke et al. (2013): Impact of treatment planning target volumen (PTV) size on radiation induced diarrhoea following selenium supplementation in gynecologic radiation oncology-a subgroup analysis of a multicenter, phase III trial No edit summary
- 12:4412:44, 12 July 2024 diff hist +540 Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology No edit summary
- 12:4312:43, 12 July 2024 diff hist +111 Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck No edit summary
- 12:4312:43, 12 July 2024 diff hist −129 Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck No edit summary
- 12:4212:42, 12 July 2024 diff hist +561 Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck No edit summary
- 12:4212:42, 12 July 2024 diff hist +721 Karp et al. (2012): Randomized, double-blind, placebo-controlled, phase III chemoprevention trial of selenium supplementation in patients with resected stage I non-small-cell lung cancer: ECOG 5597 No edit summary
- 12:4112:41, 12 July 2024 diff hist +758 Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial No edit summary
- 12:4012:40, 12 July 2024 diff hist −19 Jahangard-Rafsanjani et al. (2013): The efficacy of selenium in prevention of oral mucositis in patients undergoing hematopoietic SCT: a randomized clinical trial No edit summary
- 12:4012:40, 12 July 2024 diff hist −19 Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial No edit summary
- 12:4012:40, 12 July 2024 diff hist +835 Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial No edit summary
- 12:3912:39, 12 July 2024 diff hist +206 Büntzel et al. (2010): Selenium Substitution During Radiotherapy of Solid Tumours - Laboratory Data from Two Observation Studies in Gynaecological and Head and Neck Cancer Patients No edit summary
- 12:3812:38, 12 July 2024 diff hist +675 Büntzel et al. (2010): Limited effects of selenium in the prevention of radiation-associated toxicities - results of a randomized study in head neck cancer patients No edit summary
- 12:3712:37, 12 July 2024 diff hist +997 Asfour et al. (2006): Effect of high-dose sodium selenite therapy on polymorphonuclear leukocyte apoptosis in non-Hodgkin's lymphoma patients No edit summary
- 12:3612:36, 12 July 2024 diff hist +1,239 Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer No edit summary
- 12:3312:33, 12 July 2024 diff hist −19 Stratton et al. (2010): Oral Selenium Supplementation Has No Effect on Prostate- Specific Antigen Velocity in Men Undergoing Active Surveillance for Localized Prostate Cancer No edit summary
- 12:3012:30, 12 July 2024 diff hist +1 Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial No edit summary
- 12:2812:28, 12 July 2024 diff hist +13 Kirste et al. (2011): Boswellia serrata Acts on Cerebral Edema in Patients Irradiated for Brain Tumors. A Prospective, Randomized, Placebo-Controlled, Double-Blind Pilot Trial No edit summary
- 09:5509:55, 12 July 2024 diff hist +437 Barton et al. (2013): The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9 No edit summary